InvestorsHub Logo
icon url

frrol

12/30/19 3:07 PM

#227371 RE: WolfofMia #227359

We don't know what the trial did, it's just finishing up enrollment. You mean the initial low-dose PK/PD cohort. Yes it appears to be safe for the RS patients, which would be very good.